List of Tables
    Table 1. Infectious Disease Point of Care Diagnostics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Infectious Disease Point of Care Diagnostics Market Trends
    Table 3. Infectious Disease Point of Care Diagnostics Market Drivers
    Table 4. Infectious Disease Point of Care Diagnostics Market Challenges
    Table 5. Infectious Disease Point of Care Diagnostics Market Restraints
    Table 6. Global Infectious Disease Point of Care Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Infectious Disease Point of Care Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Infectious Disease Point of Care Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Infectious Disease Point of Care Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Infectious Disease Point of Care Diagnostics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Infectious Disease Point of Care Diagnostics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Infectious Disease Point of Care Diagnostics Revenue Share by Player, 2017-2022
    Table 13. Global Infectious Disease Point of Care Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Infectious Disease Point of Care Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2021)
    Table 15. Top Players of Infectious Disease Point of Care Diagnostics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Infectious Disease Point of Care Diagnostics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Infectious Disease Point of Care Diagnostics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Infectious Disease Point of Care Diagnostics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Infectious Disease Point of Care Diagnostics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Infectious Disease Point of Care Diagnostics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Infectious Disease Point of Care Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Infectious Disease Point of Care Diagnostics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Infectious Disease Point of Care Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Infectious Disease Point of Care Diagnostics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Infectious Disease Point of Care Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Infectious Disease Point of Care Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Infectious Disease Point of Care Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Abbott Company Details
    Table 31. Abbott Business Overview
    Table 32. Abbott Infectious Disease Point of Care Diagnostics Product
    Table 33. Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 34. Abbott Recent Development
    Table 35. Siemens Company Details
    Table 36. Siemens Business Overview
    Table 37. Siemens Infectious Disease Point of Care Diagnostics Product
    Table 38. Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 39. Siemens Recent Development
    Table 40. GE Healthcare Company Details
    Table 41. GE Healthcare Business Overview
    Table 42. GE Healthcare Infectious Disease Point of Care Diagnostics Product
    Table 43. GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 44. GE Healthcare Recent Development
    Table 45. Accriva Company Details
    Table 46. Accriva Business Overview
    Table 47. Accriva Infectious Disease Point of Care Diagnostics Product
    Table 48. Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 49. Accriva Recent Development
    Table 50. Terumo Company Details
    Table 51. Terumo Business Overview
    Table 52. Terumo Infectious Disease Point of Care Diagnostics Product
    Table 53. Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 54. Terumo Recent Development
    Table 55. BioMerieux Company Details
    Table 56. BioMerieux Business Overview
    Table 57. BioMerieux Infectious Disease Point of Care Diagnostics Product
    Table 58. BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 59. BioMerieux Recent Development
    Table 60. Diasorin Company Details
    Table 61. Diasorin Business Overview
    Table 62. Diasorin Infectious Disease Point of Care Diagnostics Product
    Table 63. Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 64. Diasorin Recent Development
    Table 65. Roche Company Details
    Table 66. Roche Business Overview
    Table 67. Roche Infectious Disease Point of Care Diagnostics Product
    Table 68. Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 69. Roche Recent Development
    Table 70. Danaher Corporation Company Details
    Table 71. Danaher Corporation Business Overview
    Table 72. Danaher Corporation Infectious Disease Point of Care Diagnostics Product
    Table 73. Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 74. Danaher Corporation Recent Development
    Table 75. BD Company Details
    Table 76. BD Business Overview
    Table 77. BD Infectious Disease Point of Care Diagnostics Product
    Table 78. BD Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 79. BD Recent Development
    Table 80. Bio-Rad Laboratories Company Details
    Table 81. Bio-Rad Laboratories Business Overview
    Table 82. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product
    Table 83. Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 84. Bio-Rad Laboratories Recent Development
    Table 85. Cavidi Company Details
    Table 86. Cavidi Business Overview
    Table 87. Cavidi Infectious Disease Point of Care Diagnostics Product
    Table 88. Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 89. Cavidi Recent Development
    Table 90. Cepheid Company Details
    Table 91. Cepheid Business Overview
    Table 92. Cepheid Infectious Disease Point of Care Diagnostics Product
    Table 93. Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 94. Cepheid Recent Development
    Table 95. Diaxonhit Company Details
    Table 96. Diaxonhit Business Overview
    Table 97. Diaxonhit Infectious Disease Point of Care Diagnostics Product
    Table 98. Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 99. Diaxonhit Recent Development
    Table 100. Eiken Chemical Company Details
    Table 101. Eiken Chemical Business Overview
    Table 102. Eiken Chemical Infectious Disease Point of Care Diagnostics Product
    Table 103. Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 104. Eiken Chemical Recent Development
    Table 105. EMD Millipore Company Details
    Table 106. EMD Millipore Business Overview
    Table 107. EMD Millipore Infectious Disease Point of Care Diagnostics Product
    Table 108. EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 109. EMD Millipore Recent Development
    Table 110. Epitope Diagnostic Company Details
    Table 111. Epitope Diagnostic Business Overview
    Table 112. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product
    Table 113. Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 114. Epitope Diagnostic Recent Development
    Table 115. Euroimmun Company Details
    Table 116. Euroimmun Business Overview
    Table 117. Euroimmun Infectious Disease Point of Care Diagnostics Product
    Table 118. Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 119. Euroimmun Recent Development
    Table 120. Gold Standard Diagnostics Company Details
    Table 121. Gold Standard Diagnostics Business Overview
    Table 122. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product
    Table 123. Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 124. Gold Standard Diagnostics Recent Development
    Table 125. Hologic Company Details
    Table 126. Hologic Business Overview
    Table 127. Hologic Infectious Disease Point of Care Diagnostics Product
    Table 128. Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 129. Hologic Recent Development
    Table 130. Immunetics Company Details
    Table 131. Immunetics Business Overview
    Table 132. Immunetics Infectious Disease Point of Care Diagnostics Product
    Table 133. Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 134. Immunetics Recent Development
    Table 135. InBios International Company Details
    Table 136. InBios International Business Overview
    Table 137. InBios International Infectious Disease Point of Care Diagnostics Product
    Table 138. InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022) & (US$ Million)
    Table 139. InBios International Recent Development
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Infectious Disease Point of Care Diagnostics Product Picture
    Figure 2. Global Infectious Disease Point of Care Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Infectious Disease Point of Care Diagnostics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Infectious Disease Point of Care Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Infectious Disease Point of Care Diagnostics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Infectious Disease Point of Care Diagnostics Market Share in Global 2017-2028
    Figure 7. Infectious Disease Point of Care Diagnostics Report Years Considered
    Figure 8. Product Picture of Over-the-counter (OTC) Testing Kits
    Figure 9. Product Picture of Prescription-based Testing Kits
    Figure 10. Global Infectious Disease Point of Care Diagnostics Market Share by Type in 2022 & 2028
    Figure 11. Global Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Infectious Disease Point of Care Diagnostics Market Share by Type (2017-2028)
    Figure 13. United States Infectious Disease Point of Care Diagnostics Market Share by Type in 2022 & 2028
    Figure 14. United States Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Infectious Disease Point of Care Diagnostics Market Share by Type (2017-2028)
    Figure 16. Product Picture of Bacterial Infections
    Figure 17. Product Picture of Fungal Infection
    Figure 18. Product Picture of Virus Infection
    Figure 19. Product Picture of Cardiovascular Infection
    Figure 20. Product Picture of Gastrointestinal Infection
    Figure 21. Product Picture of Sexually Transmitted Disease (STD) Infection
    Figure 22. Product Picture of Central Nervous System Infection
    Figure 23. Product Picture of Other
    Figure 24. Global Infectious Disease Point of Care Diagnostics Market Share by Application in 2022 & 2028
    Figure 25. Global Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. Global Infectious Disease Point of Care Diagnostics Market Share by Application (2017-2028)
    Figure 27. United States Infectious Disease Point of Care Diagnostics Market Share by Application in 2022 & 2028
    Figure 28. United States Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2028) & (US$ Million)
    Figure 29. United States Infectious Disease Point of Care Diagnostics Market Share by Application (2017-2028)
    Figure 30. North America Infectious Disease Point of Care Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. U.S. Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Canada Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Europe Infectious Disease Point of Care Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. Germany Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. France Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. U.K. Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Italy Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Russia Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 40. China Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Japan Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. South Korea Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. India Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Australia Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Taiwan Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Indonesia Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Thailand Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Malaysia Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Philippines Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Latin America Infectious Disease Point of Care Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Mexico Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Brazil Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Argentina Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 55. Turkey Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. U.A.E Infectious Disease Point of Care Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Abbott Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 59. Siemens Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 60. GE Healthcare Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 61. Accriva Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 62. Terumo Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 63. BioMerieux Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 64. Diasorin Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 65. Roche Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 66. Danaher Corporation Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 67. BD Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 68. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 69. Cavidi Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 70. Cepheid Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 71. Diaxonhit Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 72. Eiken Chemical Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 73. EMD Millipore Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 74. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 75. Euroimmun Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 76. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 77. Hologic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 78. Immunetics Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 79. InBios International Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2017-2022)
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed